FDA Warning Letter — Exer Labs, Inc.

Case 699218 — FEI 3020929899

The FDA took a Warning Letter action against Exer Labs, Inc. on February 10, 2025 (Denver, CO). The action was issued by CDRH and concerns devices products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Exer Labs, Inc.
Date
February 10, 2025
Fiscal Year
2025
Product Type
Devices
Center
CDRH
Location
Denver, CO (United States)